Michael C Sabel
Overview
Explore the profile of Michael C Sabel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1431
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sprooten J, Vanmeerbeek I, Datsi A, Govaerts J, Naulaerts S, Laureano R, et al.
Cell Rep Med
. 2024 Jan;
5(1):101377.
PMID: 38232703
Current immunotherapies provide limited benefits against T cell-depleted tumors, calling for therapeutic innovation. Using multi-omics integration of cancer patient data, we predict a type I interferon (IFN) response state of...
2.
Naulaerts S, Datsi A, Borras D, Antoranz Martinez A, Messiaen J, Vanmeerbeek I, et al.
Sci Transl Med
. 2023 Apr;
15(691):eadd1016.
PMID: 37043555
Clinically relevant immunological biomarkers that discriminate between diverse hypofunctional states of tumor-associated CD8 T cells remain disputed. Using multiomics analysis of CD8 T cell features across multiple patient cohorts and...
3.
Kamp M, Rapp M, Cornelius J, Knipps J, Muller M, von Sass C, et al.
World Neurosurg
. 2019 Dec;
133:436-437.
PMID: 31881563
No abstract available.
4.
Geisler S, Stegmayr C, Niemitz N, Lohmann P, Rapp M, Stoffels G, et al.
J Nucl Med
. 2019 Mar;
60(10):1373-1379.
PMID: 30850492
Assessment of residual tumor after resection of cerebral gliomas can be difficult with MRI and may be improved by amino acid PET. The aim of this experimental study was to...
5.
Briel-Pump A, Beez T, Ebbert L, Remke M, Weinhold S, Sabel M, et al.
J Photochem Photobiol B
. 2018 Nov;
189:298-305.
PMID: 30445362
Background: Medulloblastoma (MB) is the most common malignant primary brain tumor of childhood. High risk patients still have a poor outcome, and especially young patients suffer from standard therapy induced...
6.
Schimanski A, Ebbert L, Sabel M, Finocchiaro G, Lamszus K, Ewelt C, et al.
J Photochem Photobiol B
. 2016 Sep;
163:203-10.
PMID: 27588717
Glioblastoma (GBM) is the most frequent and lethal primary brain tumor in adults. Despite multimodal therapy combining resection, radio- and alkylating chemotherapy, disease recurrence is universal and prognosis of patients...
7.
Wick W, Roth P, Hartmann C, Hau P, Nakamura M, Stockhammer F, et al.
Neuro Oncol
. 2016 Jul;
18(11):1529-1537.
PMID: 27370396
Background: Optimal treatment and precise classification for anaplastic glioma are needed. Methods: The objective for long-term follow-up of NOA-04 is to optimize the treatment sequence for patients with anaplastic gliomas....
8.
Suchorska B, Weller M, Tabatabai G, Senft C, Hau P, Sabel M, et al.
Neuro Oncol
. 2016 Jan;
18(4):549-56.
PMID: 26823503
Background: The role of reoperation for recurrent glioblastoma (GBM) remains unclear. Prospective studies are lacking. Here, we studied the association of clinical outcome with extent of resection upon surgery for...
9.
Weller M, Tabatabai G, Kastner B, Felsberg J, Steinbach J, Wick A, et al.
Clin Cancer Res
. 2015 Feb;
21(9):2057-64.
PMID: 25655102
Purpose: Rechallenge with temozolomide (TMZ) at first progression of glioblastoma after temozolomide chemoradiotherapy (TMZ/RT→TMZ) has been studied in retrospective and single-arm prospective studies, applying temozolomide continuously or using 7/14 or...
10.
Riehmer V, Gietzelt J, Beyer U, Hentschel B, Westphal M, Schackert G, et al.
Genes Chromosomes Cancer
. 2014 Apr;
53(7):589-605.
PMID: 24706357
Molecular changes associated with the progression of glioblastoma after standard radiochemotherapy remain poorly understood. We compared genomic profiles of 27 paired primary and recurrent IDH1/2 wild-type glioblastomas by genome-wide array-based...